-
1
-
-
84859084005
-
-
4th Edition, Marcel Dekker, Inc
-
Gilbert S. Banker, Christopher T. Rhodes, Modern Pharmaceutics, 4th Edition, 121, 2005, Marcel Dekker, Inc, 501-514.
-
(2005)
Modern Pharmaceutics
, vol.121
, pp. 501-514
-
-
Gilbert, S.B.1
Christopher, T.R.2
-
5
-
-
0004603785
-
Sustained and controlled Release Drug Delivery System
-
Marcel Dekker, Inc., 3rd edition
-
Gwen M. Jantzen and Joseph R. Robinson, Sustained and controlled Release Drug Delivery System, In Modern Pharmaceutics, Marcel Dekker, Inc., 3rd edition, 1996, 582-593.
-
In Modern Pharmaceutics
, vol.1996
, pp. 582-593
-
-
Gwen, M.1
Jantzen2
Joseph, R.R.3
-
9
-
-
84859024746
-
-
British Pharmacopoeia. British Pharmacopoeial Commission office, London
-
British Pharmacopoeia. The Stationary office, MHRA, British Pharmacopoeial Commission office, Vol. 1, London, 2004.
-
(2004)
The Stationary office, MHRA
, vol.1
-
-
-
10
-
-
84859024745
-
-
5th edition
-
Raymond C Rowe, Paul J Sheskey and Sian C Owen, Hand Book Of Pharmaceutical Excipients, 5th edition, 2006, 553-560.
-
Hand Book Of Pharmaceutical Excipients
, vol.2006
, pp. 553-560
-
-
Raymond, C.R.1
Paul, J.S.2
Sian, C.O.3
-
11
-
-
84859098018
-
-
5th edition
-
Raymond C Rowe, Paul J Sheskey and Sian C Owen, Hand Book Of Pharmaceutical Excipients, 5th edition, 2006, 278-282.
-
Hand Book Of Pharmaceutical Excipients
, vol.2006
, pp. 278-282
-
-
Raymond, C.R.1
Paul, J.S.2
Sian, C.O.3
-
12
-
-
0027210077
-
Pharmacokinetics and pharmacodynamics of metoprolol after conventional and controlled-release administration in combination with hydrochlorothiazide in healthy volunteers
-
P. Lundborg et al. Pharmacokinetics and pharmacodynamics of metoprolol after conventional and controlled-release administration in combination with hydrochlorothiazide in healthy volunteers, European Journal of Clinical Pharmacology, 45(2)1993, 161-163.
-
(1993)
European Journal of Clinical Pharmacology
, vol.45
, Issue.2
, pp. 161-163
-
-
Lundborg, P.1
-
13
-
-
33344456855
-
Modulated release metoprolol succinate formulation based on ionic interactions: In vivo proof of concept
-
Hema Ravishankar et al. Modulated release metoprolol succinate formulation based on ionic interactions: In vivo proof of concept, Journal of Controlled Release, Volume 111, Issues 1-2, 2006, 65-72.
-
(2006)
Journal of Controlled Release
, vol.111
, Issue.1-2
, pp. 65-72
-
-
Hema Ravishankar1
-
14
-
-
84859054725
-
Metoprolol succinate extended release/hydrochlorothiazide combination tablets
-
James W Hainer et al. Metoprolol succinate extended release/hydrochlorothiazide combination tablets, Am J Hypertens.19 (12), 2003, 117-25.
-
(2003)
Am J Hypertens.
, vol.19
, Issue.12
, pp. 117-125
-
-
James, W.H.1
-
15
-
-
33845190200
-
Factorial antihypertensive study of an extended- release metoprolol and hydrochlorothiazide combination
-
Papademetriou V. Factorial antihypertensive study of an extended- release metoprolol and hydrochlorothiazide combination,Am J Hypertens.19(12), 2006, 1217-25.
-
(2006)
Am J Hypertens.
, vol.19
, Issue.12
, pp. 1217-1225
-
-
Papademetriou, V.1
-
16
-
-
70350510303
-
Metoprolol succinate combination in the treatment of hypertension
-
Papadopoulos DP et al. Metoprolol succinate combination in the treatment of hypertension. Angiology. 60(5), 2009, 608-13.
-
(2009)
Angiology
, vol.60
, Issue.5
, pp. 608-613
-
-
Papadopoulos, D.P.1
-
17
-
-
0026586595
-
Controlled release metoprolol formulations. A review of their pharmacodynamics and pharmacokinetic properties and therapeutic use in hypertension and ischaemic heart disease
-
Plosker GL et al. Controlled release metoprolol formulations. A review of their pharmacodynamics and pharmacokinetic properties, and therapeutic use in hypertension and ischaemic heart disease, Drugs. 1999; 43(3):382-414.
-
(1999)
Drugs.
, vol.43
, Issue.3
, pp. 382-414
-
-
Plosker, G.L.1
-
18
-
-
70449715270
-
Core-in-Cup Tablet Design of Metoprolol Succinate and its Evaluation for Controlled Release
-
Nagaraju et al. Core-in-Cup Tablet Design of Metoprolol Succinate and its Evaluation for Controlled Release, Current Drug Discovery Technologies, Volume 6, Number 4, 2009 , 299-305.
-
(2009)
Current Drug Discovery Technologies
, vol.6
, Issue.4
, pp. 299-305
-
-
Nagaraju1
-
19
-
-
0033801080
-
Natural Gums and Modified Natural Gums as Sustained-Release Carriers
-
Tilak R. Bhardwaj et al. Natural Gums and Modified Natural Gums as Sustained-Release Carriers, Drug Development and Industrial Pharmacy, Vol. 26, No. 10, 2000, 1025-1038.
-
(2000)
Drug Development and Industrial Pharmacy
, vol.26
, Issue.10
, pp. 1025-1038
-
-
Tilak, R.B.1
-
20
-
-
84859058562
-
Polymer blends for controlled release coatings
-
F. Siepmann et al. Polymer blends for controlled release coatings, Indian Journal of Pharmaceutical Sciences, 61(6), 1996, 42-5.
-
(1996)
Indian Journal of Pharmaceutical Sciences
, vol.61
, Issue.6
, pp. 42-45
-
-
Siepmann, F.1
-
21
-
-
84859041586
-
Modified guar gum matrix tablet for controlled release of diltiazem hydrochloride
-
Udaya S. Toti et al., Modified guar gum matrix tablet for controlled release of diltiazem hydrochloride, Indian Journal of Pharmaceutical Sciences, 61(6), 1998, 212-5.
-
(1998)
Indian Journal of Pharmaceutical Sciences
, vol.61
, Issue.6
, pp. 212-215
-
-
Udaya S.Toti1
-
22
-
-
0004512935
-
Guar Gum as a hydrophilic matrix for preparation of Theophylline Controlled Release dosage form
-
Khullar P et al., Guar Gum as a hydrophilic matrix for preparation of Theophylline Controlled Release dosage form, Indian Journal of Pharmaceutical Sciences, 61(6), 1999, 342-5.
-
(1999)
Indian Journal of Pharmaceutical Sciences
, vol.61
, Issue.6
, pp. 342-345
-
-
Khullar, P.1
|